The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACUTUS MEDICAL INC | COM | 005111109 | 22,350 | 749,990 | SH | SOLE | 749,990 | 0 | 0 | ||
| ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 6,130 | 1,487,800 | SH | SOLE | 1,487,800 | 0 | 0 | ||
| AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 2,659 | 375,000 | SH | SOLE | 375,000 | 0 | 0 | ||
| AMARIN CORP PLC | SPONSORED ADR NEW | 023111206 | 947 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
| APTOSE BIOSCIENCES INC | COM NEW | 03835T200 | 10,794 | 1,799,000 | SH | SOLE | 1,799,000 | 0 | 0 | ||
| AVENUE THERAPEUTICS INC | COM NEW | 05360L205 | 10,664 | 984,692 | SH | SOLE | 984,692 | 0 | 0 | ||
| AXOVANT SCIENCES LTD | COM | G0750W203 | 9,421 | 2,039,100 | SH | SOLE | 2,039,100 | 0 | 0 | ||
| BIOHAVEN PHARMACEUTICAL HLDG | COM | G11196105 | 7,434 | 114,350 | SH | SOLE | 114,350 | 0 | 0 | ||
| BIOLINERX LTD | SPONSORED ADS | 09071M205 | 33 | 16,667 | SH | SOLE | 16,667 | 0 | 0 | ||
| CARDIFF ONCOLOGY INC | COM | 14147L108 | 24,571 | 1,731,600 | SH | SOLE | 1,731,600 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC | COM NEW | 15117B202 | 14,711 | 992,000 | SH | SOLE | 992,000 | 0 | 0 | ||
| CERECOR INC | COM | 15671L109 | 7,678 | 3,372,500 | SH | SOLE | 3,372,500 | 0 | 0 | ||
| CHEMOCENTRYX INC | COM | 16383L106 | 19,509 | 356,000 | SH | SOLE | 356,000 | 0 | 0 | ||
| CHIMERIX INC | COM | 16934W106 | 9,565 | 3,841,500 | SH | SOLE | 3,841,500 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 2,766 | 970,664 | SH | SOLE | 970,664 | 0 | 0 | ||
| CODEXIS INC | COM | 192005106 | 16,436 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | ||
| CONCERT PHARMACEUTICALS INC | COM | 206022105 | 982 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| CONTRAFECT INC | COM NEW | 212326300 | 1,194 | 226,127 | SH | SOLE | 226,127 | 0 | 0 | ||
| CRINETICS PHARMACEUTICALS INC | COM | 22663K107 | 3,761 | 240,000 | SH | SOLE | 240,000 | 0 | 0 | ||
| CYTOKINETICS INC | COM NEW | 23282W605 | 4,521 | 208,800 | SH | SOLE | 208,800 | 0 | 0 | ||
| DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 11,389 | 222,000 | SH | SOLE | 222,000 | 0 | 0 | ||
| EDAP TMS SA | SPONSORED ADR | 268311107 | 4,784 | 1,040,000 | SH | SOLE | 1,040,000 | 0 | 0 | ||
| EIDOS THERAPEUTICS INC | COM | 28249H104 | 15,945 | 315,550 | SH | SOLE | 315,550 | 0 | 0 | ||
| ESSA PHARMA INC | COM NEW | 29668H708 | 1,872 | 271,350 | SH | SOLE | 271,350 | 0 | 0 | ||
| ETON PHARMACEUTICALS INC | COM | 29772L108 | 28,756 | 3,640,000 | SH | SOLE | 3,640,000 | 0 | 0 | ||
| FIBROGEN INC | COM | 31572Q808 | 6,045 | 147,000 | SH | SOLE | 147,000 | 0 | 0 | ||
| FORTRESS BIOTECH INC | COM | 34960Q109 | 10,264 | 3,830,000 | SH | SOLE | 3,830,000 | 0 | 0 | ||
| FULCRUM THERAPEUTICS INC | COM | 359616109 | 3,584 | 452,000 | SH | SOLE | 452,000 | 0 | 0 | ||
| HARROW HEALTH INC | COM | 415858109 | 16,541 | 2,959,000 | SH | SOLE | 2,959,000 | 0 | 0 | ||
| INFINITY PHARMACEUTICALS INC | COM | 45665G303 | 137 | 3,171,800 | SH | SOLE | 3,171,800 | 0 | 0 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 5,863 | 470,203 | SH | SOLE | 470,203 | 0 | 0 | ||
| KEZAR LIFE SCIENCES INC | COM | 49372L100 | 3,282 | 678,000 | SH | SOLE | 678,000 | 0 | 0 | ||
| KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | 8,778 | 338,000 | SH | SOLE | 338,000 | 0 | 0 | ||
| LUMOS PHARMA INC | COM | 55028X109 | 3,329 | 240,892 | SH | SOLE | 240,892 | 0 | 0 | ||
| MACROGENICS INC | COM | 556099109 | 13,275 | 527,000 | SH | SOLE | 527,000 | 0 | 0 | ||
| MEI PHARMA INC | COM NEW | 55279B202 | 4,855 | 1,556,000 | SH | SOLE | 1,556,000 | 0 | 0 | ||
| MERUS NV | COM | N5749R100 | 2 | 200 | SH | SOLE | 200 | 0 | 0 | ||
| MINERVA NEUROSCIENCES INC | COM | 603380106 | 2,440 | 767,400 | SH | SOLE | 767,400 | 0 | 0 | ||
| MYOVANT SCIENCES LTD | COM | G637AM102 | 9,589 | 682,500 | SH | SOLE | 682,500 | 0 | 0 | ||
| NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | 16,636 | 1,386,300 | SH | SOLE | 1,386,300 | 0 | 0 | ||
| OCULAR THERAPEUTIX INC | COM | 67576A100 | 45,540 | 5,984,200 | SH | SOLE | 5,984,200 | 0 | 0 | ||
| ONCTERNAL THERAPEUTICS INC | COM | 68236P107 | 331 | 194,541 | SH | SOLE | 194,541 | 0 | 0 | ||
| OUTSET MED INC | COM | 690145107 | 2,250 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
| PIERIS PHARMACEUTICALS INC | COM | 720795103 | 300 | 145,000 | SH | SOLE | 145,000 | 0 | 0 | ||
| PROTARA THERAPEUTICS INC | COM STK | 74365U107 | 43,059 | 2,558,472 | SH | SOLE | 2,558,472 | 0 | 0 | ||
| SERES THERAPEUTICS | COM | 81750R102 | 9,493 | 335,312 | SH | SOLE | 335,312 | 0 | 0 | ||
| STEREOTAXIS INC | COM NEW | 85916J409 | 10,817 | 3,021,436 | SH | SOLE | 3,021,436 | 0 | 0 | ||
| SUTRO BIOPHARMA INC | COM | 869367102 | 1,467 | 146,000 | SH | SOLE | 146,000 | 0 | 0 | ||
| TELA BIO INC | COM | 872381108 | 5,989 | 362,074 | SH | SOLE | 362,074 | 0 | 0 | ||
| TG THERAPEUTICS INC | COM | 88322Q108 | 10,436 | 390,000 | SH | SOLE | 390,000 | 0 | 0 | ||
| TRACON PHARMACEUTICALS INC | COM NEW | 89237H209 | 10,409 | 2,013,438 | SH | SOLE | 2,013,438 | 0 | 0 | ||
| VAXCYTE | COM | 92243G108 | 15,456 | 313,000 | SH | SOLE | 313,000 | 0 | 0 | ||
| VERASTEM INC | COM | 92337C104 | 3,201 | 2,200,000 | SH | SOLE | 2,200,000 | 0 | 0 | ||
| X4 PHARMACEUTICALS INC | COM | 98420X103 | 508 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| XOMA CORP DEL | COM NEW | 98419J206 | 8,572 | 455,000 | SH | SOLE | 455,000 | 0 | 0 | ||